This study evaluates the impact of primary and secondary nonadherence to cholesterol medication on low-density lipoprotein levels, emergency department visits, and hospitalizations.
Geoffrey Joyce, PhD
Advertisement
Articles by Geoffrey Joyce, PhD
Advertisement
Latest Updated Articles
- Outcomes Associated With Primary and Secondary Nonadherence to Cholesterol Medications
Published: April 18th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
3
Breaking News: CVS Buys Rite Aid, Bartell Drugs
4
Current and Emerging BCMAxCD3 Bispecifics
5
